Individual neurochemistry varies significantly, and some people simply do not respond well to DSIP regardless of protocol optimization
In addition to the studies demonstrating the central effects of GLP-1 and its analogs on satiety and reduction of energy intake, there are studies showing other central effects of GLP-1 involving BAT
Statements estimating treatment duration and the number of treatments required are based on the typical experience of our patients, however, individual experiences may vary.
BPC-157 continues to gain serious attention in regenerative and performance medicine
GLP-1 agonists are not expensive to produce, however, and the patent on Ozempic expired in January of 2026 in Canada and China (and lasts until 2030 in the U.S.), but I expect the market to bring the costs down dramatically over the next few years
Perfect for women looking for a chemical-free alternative to soaps